The streptavidin-biotin interaction is widely used to enhance the sensitivity of immunodetection assays due to its exceptionally high affinity (Kd ≈ 10−14 M). Streptavidin-conjugated anti-hamster primary antibodies are immunochemical reagents designed for the detection of target antigens in hamster-derived samples through biotin-streptavidin amplification systems. Produced by immunizing host species such as goat or rabbit with purified hamster immunoglobulins, these antibodies are purified by immunoaffinity chromatography and conjugated to streptavidin, a tetrameric protein derived from Streptomyces avidinii. This conjugation enables subsequent detection using biotinylated enzymes, fluorophores, or other reporter molecules, providing efficient signal amplification. Depending on the product, these antibodies may recognize hamster immunoglobulin heavy and light chains (H+L) or specific immunoglobulin isotypes. Many formulations are pre-adsorbed against serum proteins from other species to minimize cross-reactivity and improve assay specificity.
Applications
Streptavidin-conjugated anti-hamster primary antibodies are widely employed in immunoassays requiring enhanced sensitivity through biotin-mediated signal amplification. In immunohistochemistry (IHC) and immunocytochemistry (ICC), streptavidin-biotin detection systems improve the visualization of antigens in tissue sections and cultured cells. In ELISA and Western blotting, these reagents enable sensitive detection and quantification of target proteins when combined with biotinylated detection molecules. Additional applications include in situ hybridization, flow cytometry, and protein array technologies. Optimal antibody dilution should be determined empirically for each experimental protocol. These reagents are intended exclusively for research use and are not approved for diagnostic or therapeutic applications.